Skip to main content

Spectrum: Autism Research News

Tag: clinical trials

December 2010

Molecular mechanisms: Lithium treats adult fragile X symptoms

by  /  8 December 2010

Treating adult mice with lithium restores the ability of neurons in fragile X mice to fine-tune their signaling, according to a study published online in November in Brain Research.

Comments
November 2010

Antibiotic proves promising as fragile X treatment

by  /  19 November 2010

Minocycline, an antibiotic approved to treat various infections including acne, can increase vocalizations and provide long-lasting improvements in anxiety in a fragile X mouse model, according to two posters presented at the Society for Neuroscience annual meeting in San Diego.

Comments

Stem cell assay reveals early development of Rett neurons

by  /  16 November 2010

Researchers have developed the first stem cell system that makes it possible to study the early development of neurons from people with Rett syndrome, a rare disorder on the autism spectrum.

Comments

Prairie vole study finds new drug that boosts oxytocin

by  /  15 November 2010

A drug already in clinical trials as a tanning compound raises brain levels of oxytocin — a hormone and neurotransmitter involved in social bonding — researchers reported Sunday at the Society for Neuroscience annual meeting in San Diego. Higher levels of oxytocin can help animals recognize their mates and turn to a friend for help, according to two posters presented at the meeting.

Comments
October 2010

Database groups common concepts in autism tests

by  /  27 October 2010

A searchable new database will greatly ease the task of comparing results from more than 25 diagnostic tests for autism, by creating clusters of the various symptoms measured.

Comments
September 2010

Fragile X protein tied to snags in stem cell development

by  /  13 September 2010

The protein missing in fragile X syndrome is necessary for the proper development of neural stem cells — self-renewing cells that can differentiate into more specialized types, including neurons — according to a paper published in the August issue of Human Molecular Genetics.

Comments

One drug, two birds

by  /  10 September 2010

Seaside Therapeutics has announced results from a phase II clinical trial showing that, in children with autism, STX209 lowers agitation, tantrums, irritability and social withdrawal.

Comments
August 2010

Studies explore amygdala problems in fragile X syndrome

by  /  31 August 2010

The amygdala, a brain region that regulates fear and anxiety, shows abnormal neuronal signaling in a mouse model of fragile X syndrome, according to two studies published this summer. These are the first to explore cellular defects in the region in fragile X.

Comments

Fragile X protein linked to potassium channels

by  /  24 August 2010

Mouse models of fragile X syndrome show defects in two kinds of potassium channels — ubiquitous pores that control the flow of electrical current across neurons — in a brain area that processes sound, according to two papers published this summer.

Comments
July 2010

Scientists flash videos of brain development in fragile X

by  /  30 July 2010

Scientists have for the first time captured a dynamic picture of brain defects in young mouse models of fragile X syndrome. The findings appeared in June in the Journal of Neuroscience.

Comments